
The new report "Myasthenia Gravis Disease Market, [By Disease Type (Imaging (X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Others), Blood Tests, Electrodiagnostic, and Edrophonium Test), By Treatment (Medication, Surgery, and HSCT), By End-User (Hospitals, Clinics, and Academic Research Institutes) By Region]: Market Size & Forecast, 2018 – 2026" The global Myasthenia Gravis Disease Market is estimated to reach USD 2,538.6 million by 2026 from USD 1,012.2 million in 2017. The market is anticipated to grow at a CAGR of 10.8% during the forecast period.